Skip to main content

Advice for Good Laboratory Practice facilities in relation to coronavirus (COVID-19)

Posted by: , Posted on: - Categories: Compliance matters, Good laboratory practice
Diagram demonstrating that factors such as policy. standards, control, regulations and laws are all building blocks for compliance

It is recognised that there are potential challenges specific to GLP facilities and studies at this time. The aim of this post is to provide you with information that will enable a flexible but compliant approach during this period.

MHRA Good Practice (GxP) inspections during the COVID19 outbreak

Virus particle

The COVID19 pandemic presents an unprecedented challenge to healthcare, the pharmaceutical industry’s supply chain and personnel movement. MHRA understands the impact of its work on industry, NHS and patients.

Maintaining control: Remote working and QP certification

Posted by: , Posted on: - Categories: Compliance matters, Good manufacturing practice
Laptop, papers, phone and a cup of coffee at a desk

In the modern world it is increasingly common to see flexible, part-time or home working arrangements. The pharmaceutical industry is no exception, and with some companies employing a part-time or contract Qualified Person (QP), it is no surprise that the QP continues to play a key role even when away from the site.